AstraZeneca partners with Sun Pharma to expand access to hyperkalaemia treatment Lokelma

Under the agreement, AstraZeneca will sell SZC under the brand Lokelma, while Sun Pharma will distribute it as Gimliand.

Hims & Hers Names Deb Autor as Chief Policy Officer to Lead Global Policy and Regulatory Strategy

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Deb Autor as the company’s first Chief Policy Officer. In this new role, Autor will ...
CNBCTV18

AstraZeneca Pharma and Sun Pharma enter second brand partnership for SZC in India

AstraZeneca will market the therapy as Lokelma, while Sun Pharma will promote and distribute it as Gimliand. AstraZeneca will ...

Trump is right: He lowered some of your costs. But he also made many prices higher

President Donald Trump keeps downplaying America’s affordability crisis, and he continues to falsely claim that inflation and ...

What Is One of the Best Quantum Computing Stocks to Buy Now?

Quantum computing is an early-stage technology; all of the pure-play companies in the space are high-risk investments.
Chemistry World

One medical inhaler can have the impact of 30kg of carbon dioxide

Propellants in asthma inhalers produce greenhouse gas emissions equivalent to driving 200 miles, yet most healthcare systems ...

Drug companies say AI technology is speeding up research

Traditionally, developing a new drug can take over a decade, but AI technology is changing that timeline. Major pharmaceutical companies like Pfizer and AstraZeneca are leveraging AI to accelerate the ...